NEWS & VIEWS

Global private equity and venture capital news and research

Advanced
search

Eleven Biotherapeutics raises $50m via IPO

7 Feb 2014

dollar envelope moneyVenture capital-backed biopharmaceutical company Eleven Biotherapeutics has raised $50m via an IPO on the Nasdaq exchange.

Sorry, to get access to this you need to subscribe for free.

In order to view more content, sign-up to our free daily newsletter.

If you would like to read the premium stories, have complete access to our breaking news and Limited Partner magazine you need to become a Premium Subscriber.

Subscribe to AltAssets today

Login to AltAssets

Infrastructure LP-GP Forum 2016
AltAssets Premium Sign Up Now!

Sitemap

Popular Tags

private equity buyout venture capital fundraising buy-out exit fund emerging markets fundraise IPO US fund close healthcare real estate technology mid-market infrastructure retail KKR software energy secondaries LP financial services growth capital Blackstone M&A consumer manufacturing cleantech Carlyle fund of funds online food growth equity debt Series B UK renewable energy Bain Capital medical acquisitions Europe Series A IT TPG Capital telecommunications media Series C industrial insurance Goldman Sachs internet new fund CVC Capital Partners lower mid-market Apollo Global Management mezzanine pension fund life sciences Warburg Pincus business services mobile pharmaceutical deals Advent International Permira report early stage MBO oil & gas Apax Partners fund news Sequoia Capital education hard cap oil and gas oil EQT research automotive sale Cinven cloud financing round Ardian banking 3i gas Accel Partners clothing transactions New Enterprise Associates biotech Kleiner Perkins Caufield & Byers credit TPG china The Carlyle Group corporate venture capital

Legals & Terms of Use • Privacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016

log